|Articles|August 1, 2010
- BioPharm International-08-01-2010
- Volume 23
- Issue 8
BioPharm International, August 2010 Issue (PDF)
Facilitate Cell Culture Process Development
Advertisement
Articles in this issue
over 15 years ago
Downstream Disposables: The Missing Link in the Disposables Chainover 15 years ago
Tug of Warover 15 years ago
Spanning the Globeover 15 years ago
Myriad Decision Places Biotech at a Crossroadsover 15 years ago
Manufacturing Compliance in the Spotlightover 15 years ago
USP <63> Mycoplasma Tests: A New Regulation for Mycoplasma TestingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Implications of the First Liquid IV Infliximab Biosimilar
2
GSK Bets $50M on LTZ’s Immune-Engager Platform for Next-Gen Cancer Treatment
3
Risks, Resource Strain, and Trade-Offs in FDA’s CNPV Pilot Program
4
Why 503B Compounding Pharmacies Choose Prefabricated POD® Cleanrooms
5
